ESR1 mutations: Pièce de résistance

Estrogen and estrogen receptor-alpha (ER) signaling are important factors in the pathogenesis and treatment of ER-positive breast cancers. Therefore targeted therapies against ER, known as endocrine therapies, are widely used in the treatment of ER-positive breast cancers. While these therapies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Button, Berry, Park, Ben Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150098/
https://www.ncbi.nlm.nih.gov/pubmed/30258881
http://dx.doi.org/10.1016/j.gendis.2016.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150098/
https://www.ncbi.nlm.nih.gov/pubmed/30258881
http://dx.doi.org/10.1016/j.gendis.2016.03.005

Ejemplares similares